67 related articles for article (PubMed ID: 22285275)
1. Effects of zonisamide on tardive dyskinesia: a preliminary open-label trial.
Iwata Y; Irie S; Uchida H; Suzuki T; Watanabe K; Iwashita S; Mimura M
J Neurol Sci; 2012 Apr; 315(1-2):137-40. PubMed ID: 22285275
[TBL] [Abstract][Full Text] [Related]
2. Open-label, long-term safety study of zonisamide administered to children and adolescents with epilepsy.
Shinnar S; Pellock JM; Conry JA
Eur J Paediatr Neurol; 2009 Jan; 13(1):3-9. PubMed ID: 18343174
[TBL] [Abstract][Full Text] [Related]
3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.
Bai YM; Yu SC; Lin CC
J Clin Psychiatry; 2003 Nov; 64(11):1342-8. PubMed ID: 14658949
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of melatonin in tardive dyskinesia.
Castro F; Carrizo E; Prieto de Rincón D; Rincón CA; Asián T; Medina-Leendertz S; Bonilla E
Invest Clin; 2011 Sep; 52(3):252-60. PubMed ID: 21950196
[TBL] [Abstract][Full Text] [Related]
5. Levetiracetam in tardive dyskinesia.
Meco G; Fabrizio E; Epifanio A; Morgante F; Valente M; Vanacore N; Di Rosa AE; Morgante L
Clin Neuropharmacol; 2006; 29(5):265-8. PubMed ID: 16960471
[TBL] [Abstract][Full Text] [Related]
6. Is adjunctive open-label zonisamide effective for bipolar disorder?
Ghaemi SN; Shirzadi AA; Klugman J; Berv DA; Pardo TB; Filkowski MM
J Affect Disord; 2008 Jan; 105(1-3):311-4. PubMed ID: 17586053
[TBL] [Abstract][Full Text] [Related]
7. Vitamin B6 in treatment of tardive dyskinesia: a preliminary case series study.
Lerner V; Kaptsan A; Miodownik C; Kotler M
Clin Neuropharmacol; 1999; 22(4):241-3. PubMed ID: 10442256
[TBL] [Abstract][Full Text] [Related]
8. Bilateral deep brain stimulation of the globus pallidus to treat tardive dyskinesia.
Damier P; Thobois S; Witjas T; Cuny E; Derost P; Raoul S; Mertens P; Peragut JC; Lemaire JJ; Burbaud P; Nguyen JM; Llorca PM; Rascol O;
Arch Gen Psychiatry; 2007 Feb; 64(2):170-6. PubMed ID: 17283284
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
10. Buspirone in the treatment of tardive dyskinesia.
Moss LE; Neppe VM; Drevets WC
J Clin Psychopharmacol; 1993 Jun; 13(3):204-9. PubMed ID: 8102622
[TBL] [Abstract][Full Text] [Related]
11. Acute treatment of bipolar depression with adjunctive zonisamide: a retrospective chart review.
Baldassano CF; Ghaemi SN; Chang A; Lyman A; Lipari M
Bipolar Disord; 2004 Oct; 6(5):432-4. PubMed ID: 15383137
[TBL] [Abstract][Full Text] [Related]
12. Drug therapies for tardive dyskinesia: Part 1.
Howland RH
J Psychosoc Nurs Ment Health Serv; 2011 Jun; 49(6):13-6. PubMed ID: 21598866
[TBL] [Abstract][Full Text] [Related]
13. Zonisamide for the treatment of Parkinson's disease.
Miwa H
Expert Rev Neurother; 2007 Sep; 7(9):1077-83. PubMed ID: 17868006
[TBL] [Abstract][Full Text] [Related]
14. Risperidone in the treatment of affective illness and obsessive-compulsive disorder.
Jacobsen FM
J Clin Psychiatry; 1995 Sep; 56(9):423-9. PubMed ID: 7545159
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia.
Li H; Rui Q; Ning X; Xu H; Gu N
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1002-8. PubMed ID: 21315787
[TBL] [Abstract][Full Text] [Related]
16. A double-blind placebo-controlled study of vitamin E treatment of tardive dyskinesia.
Lohr JB; Caligiuri MP
J Clin Psychiatry; 1996 Apr; 57(4):167-73. PubMed ID: 8601552
[TBL] [Abstract][Full Text] [Related]
17. Zonisamide monotherapy for epilepsy in children and young adults.
Wilfong AA
Pediatr Neurol; 2005 Feb; 32(2):77-80. PubMed ID: 15664764
[TBL] [Abstract][Full Text] [Related]
18. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
Go CL; Rosales RL; Caraos RJ; Fernandez HH
Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
[TBL] [Abstract][Full Text] [Related]
19. Utilization of zonisamide in patients with chronic pain or epilepsy refractory to other treatments: a retrospective, open label, uncontrolled study in a VA hospital.
Hasegawa H
Curr Med Res Opin; 2004 May; 20(5):577-80. PubMed ID: 15140322
[TBL] [Abstract][Full Text] [Related]
20. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
Lee JG; Shin BS; Lee YC; Park SW; Kim YH
Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
